Stocks To Buy: Nuvama sees 40% upside for this IT BPO healthcare service provider

Nuvama expects Sagility’s revenue in US Dollar terms to grow at a Compounded Annual Growth Rate (CAGR) of 13% over financial year 2026-2029, while its adjusted EPS could grow at a 19% CAGR over the same timeframe. EBITDA margins of the company can sustain between 24% to 25%.

Leave a Reply

Your email address will not be published. Required fields are marked *